[go: up one dir, main page]

WO2006091222A3 - Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118 - Google Patents

Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118 Download PDF

Info

Publication number
WO2006091222A3
WO2006091222A3 PCT/US2005/023640 US2005023640W WO2006091222A3 WO 2006091222 A3 WO2006091222 A3 WO 2006091222A3 US 2005023640 W US2005023640 W US 2005023640W WO 2006091222 A3 WO2006091222 A3 WO 2006091222A3
Authority
WO
WIPO (PCT)
Prior art keywords
avr118
sars
methods
treating
acute respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/023640
Other languages
French (fr)
Other versions
WO2006091222A2 (en
Inventor
Shalom Z Hirschman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Viral Research Corp
Original Assignee
Advanced Viral Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Viral Research Corp filed Critical Advanced Viral Research Corp
Publication of WO2006091222A2 publication Critical patent/WO2006091222A2/en
Publication of WO2006091222A3 publication Critical patent/WO2006091222A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to methods for treating Several Acute Respiratory Syndrome (SARS). Specifically, methods for treating patients having SARS comprising administering an effective amount of AVR118, alone or in combination with another medicament, are disclosed. Pharmaceutical compositions and kits comprising AVR118, an additional medicament, and pharmaceutically acceptable carriers are also disclosed.
PCT/US2005/023640 2004-07-01 2005-06-30 Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118 Ceased WO2006091222A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58485104P 2004-07-01 2004-07-01
US60/584,851 2004-07-01

Publications (2)

Publication Number Publication Date
WO2006091222A2 WO2006091222A2 (en) 2006-08-31
WO2006091222A3 true WO2006091222A3 (en) 2006-10-12

Family

ID=36927862

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/023640 Ceased WO2006091222A2 (en) 2004-07-01 2005-06-30 Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118

Country Status (1)

Country Link
WO (1) WO2006091222A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528098B2 (en) 1996-10-22 2003-03-04 Advanced Viral Research Corp. Preparation of a therapeutic composition
WO2021199003A1 (en) * 2020-04-02 2021-10-07 Vascular Biogenics Ltd. Oxidized lipids and treatment or prevention of inflammation or infectious disease caused by coronavirus infection
WO2022087109A1 (en) * 2020-10-20 2022-04-28 Eom Pharmaceuticals Inc. Eom613 for treatment of covid-19

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LAZZARINO D. A. ET AL.: "CXCR4 and CCR5 Epresion by H9 T-cells is Downregulated by a Peptide-nucleic Acid Immunomodulator", IMMUNOLOGY, vol. 74, 2000, pages 189 - 195 *
LAZZARINO D. A. ET AL.: "IL-8 and MCP-1 secretion is Enhanced by the Peptides-nucleic Acid Immunomodulator, Product R, in U937 Cells and Primary Human Monocytes", CYTOKINE, vol. 14, no. 4, 2001, pages 234 - 239 *

Also Published As

Publication number Publication date
WO2006091222A2 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
WO2005020885A3 (en) Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
WO2005023083A3 (en) Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2006086107A3 (en) Methods and compositions for minimizing accrual of inhalable insulin in the lungs
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2006060507A3 (en) Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders
WO2004075832A3 (en) Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof
WO2007061661A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2007131168A3 (en) Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
WO2004043341A3 (en) Treatment for hemorrhagic shock
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
WO2006124698A3 (en) Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting
WO2005009460A3 (en) Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
WO2010045417A3 (en) Combination therapies for the treatment of obesity
WO2005077103A3 (en) Compositions and methods for modification and prevention of sars coronavirus infectivity
WO2007123848A3 (en) Therapeutic compositions containing modified class i slrp proteins
WO2004046309A3 (en) Methods for inhibiting viral replication in vivo
EP1719515A3 (en) Glycyrrhizin or derivatives thereof for treating or preventing togavirus infections
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
WO2007133944A3 (en) Topical administration of acyclovir
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase